Paper36088362
Immunologically "cold" triple negative breast cancers engraft at a higher rate in patient derived xenografts.
Petrosyan V and 8 others. NPJ Breast Cancer, 2022. Cited by 18 papers, by iCite.
Cite this record
ConductScience Library. Immunologically "cold" triple negative breast cancers engraft at a higher rate in patient derived xenografts. Papers, record 36088362. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/36088362
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Immunologically "cold" triple negative breast cancers engraft at a higher rate in patient derived xenografts.
- PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
Grants5
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| U54 CA224076 | NCI NIH HHS | United States | U54CA224076 | PubMed and NIH | NIH RePORTER |
| U24 CA226110 | NCI NIH HHS | United States | U24CA226110 | PubMed | NIH RePORTER |
| U54 DA036134 | NIDA NIH HHS | United States | U54DA036134 | PubMed | NIH RePORTER |
| U54 DA049098 | NIDA NIH HHS | United States | U54DA049098 | PubMed | NIH RePORTER |
| P50 CA186784 | NCI NIH HHS | United States | P50CA186784 | PubMed | NIH RePORTER |
References44
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 23737486 | A renewable tissue resource of phenotypically stable, biologically and ethnically diverse, patient-derived human breast cancer xenograft models. | Cancer Res | 2013 | https://conductscience.org/library/papers/23737486 | PubMed |
| 2 | 30853353 | Genomic and Transcriptomic Landscape of Triple-Negative Breast Cancers: Subtypes and Treatment Strategies. | Cancer Cell | 2019 | https://conductscience.org/library/papers/30853353 | PubMed |
| 3 | 31102428 | Regulatory T (Treg) cells in cancer: Can Treg cells be a new therapeutic target? | Cancer Sci | 2019 | https://conductscience.org/library/papers/31102428 | PubMed |
| 4 | 33296659 | Regulatory T Cells Support Breast Cancer Progression by Opposing IFN-γ-Dependent Functional Reprogramming of Myeloid Cells. | Cell Rep | 2020 | https://conductscience.org/library/papers/33296659 | PubMed |
| 5 | 28025748 | Patient-derived xenograft (PDX) models in basic and translational breast cancer research. | Cancer Metastasis Rev | 2016 | https://conductscience.org/library/papers/28025748 | PubMed |
| 6 | 30386679 | Tumor mutational burden is a determinant of immune-mediated survival in breast cancer. | Oncoimmunology | 2018 | https://conductscience.org/library/papers/30386679 | PubMed |
| 7 | 18042719 | CD4+CD25+Foxp3+ regulatory T cells induce alternative activation of human monocytes/macrophages. | Proc Natl Acad Sci U S A | 2007 | https://conductscience.org/library/papers/18042719 | PubMed |
| 8 | 10592173 | KEGG: kyoto encyclopedia of genes and genomes. | Nucleic Acids Res | 2000 | https://conductscience.org/library/papers/10592173 | PubMed |
| 9 | 22689758 | Xenome--a tool for classifying reads from xenograft samples. | Bioinformatics | 2012 | https://conductscience.org/library/papers/22689758 | PubMed |
| 10 | 28499452 | Current status and perspectives of patient-derived xenograft models in cancer research. | J Hematol Oncol | 2017 | https://conductscience.org/library/papers/28499452 | PubMed |
| 11 | 12631387 | Breast cancer cell lines: friend or foe? | Breast Cancer Res | 2003 | https://conductscience.org/library/papers/12631387 | PubMed |
| 12 | 20661468 | Tumor-derived microvesicles induce, expand and up-regulate biological activities of human regulatory T cells (Treg). | PLoS One | 2010 | https://conductscience.org/library/papers/20661468 | PubMed |
| 13 | 25993181 | Triple-negative breast cancer: immune modulation as the new treatment paradigm. | Am Soc Clin Oncol Educ Book | 2015 | https://conductscience.org/library/papers/25993181 | PubMed |
| 14 | 27556158 | Comprehensive comparison of molecular portraits between cell lines and tumors in breast cancer. | BMC Genomics | 2016 | https://conductscience.org/library/papers/27556158 | PubMed |
| 15 | 22019887 | Tumor grafts derived from women with breast cancer authentically reflect tumor pathology, growth, metastasis and disease outcomes. | Nat Med | 2011 | https://conductscience.org/library/papers/22019887 | PubMed |
| 16 | 23372829 | Multiple breast cancer cell-lines derived from a single tumor differ in their molecular characteristics and tumorigenic potential. | PLoS One | 2013 | https://conductscience.org/library/papers/23372829 | PubMed |
| 17 | 25634491 | Comparison of 2D- and 3D-culture models as drug-testing platforms in breast cancer. | Oncol Rep | 2015 | https://conductscience.org/library/papers/25634491 | PubMed |
| 18 | 30396909 | Exosomes Released from Tumor-Associated Macrophages Transfer miRNAs That Induce a Treg/Th17 Cell Imbalance in Epithelial Ovarian Cancer. | Cancer Immunol Res | 2018 | https://conductscience.org/library/papers/30396909 | PubMed |
| 19 | 31931698 | Guidelines for cell-type heterogeneity quantification based on a comparative analysis of reference-free DNA methylation deconvolution software. | BMC Bioinformatics | 2020 | https://conductscience.org/library/papers/31931698 | PubMed |
| 20 | 33365025 | Tumor-Associated Macrophages in Tumor Immunity. | Front Immunol | 2020 | https://conductscience.org/library/papers/33365025 | PubMed |
Cited by13
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 18 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42035192 | CD8 immunoPET imaging to stratify response and guide combination immunotherapy and radiation in triple negative breast cancer. | Breast Cancer Res | 2026 | https://conductscience.org/library/papers/42035192 | PubMed |
| 42023233 | A comprehensive analysis of humanized mouse models for the study of cancer immunotherapies. | Front Immunol | 2026 | https://conductscience.org/library/papers/42023233 | PubMed |
| 40801311 | An Annotated Biobank of Triple-Negative Breast Cancer Patient-Derived Xenografts Features Treatment-Naïve and Longitudinal Samples during Neoadjuvant Chemotherapy. | Cancer Res | 2025 | https://conductscience.org/library/papers/40801311 | PubMed |
| 40710292 | The Activity of Human NK Cells Towards 3D Heterotypic Cellular Tumor Model of Breast Cancer. | Cells | 2025 | https://conductscience.org/library/papers/40710292 | PubMed |
| 40537829 | Hope for OTHERS (Our Tissue Helping Enhance Research & Science): research results from the University of Pittsburgh rapid autopsy program for breast cancer. | Breast Cancer Res | 2025 | https://conductscience.org/library/papers/40537829 | PubMed |
| 40281554 | Reprogramming the breast tumor immune microenvironment: cold-to-hot transition for enhanced immunotherapy. | J Exp Clin Cancer Res | 2025 | https://conductscience.org/library/papers/40281554 | PubMed |
| 39827242 | Steroid hormone receptors, exome sequencing and treatment responsiveness of breast cancer patient-derived xenografts originated in a South American country. | Sci Rep | 2025 | https://conductscience.org/library/papers/39827242 | PubMed |
| 39230699 | PEPerMINT: peptide abundance imputation in mass spectrometry-based proteomics using graph neural networks. | Bioinformatics | 2024 | https://conductscience.org/library/papers/39230699 | PubMed |
| 38821942 | Representation of genomic intratumor heterogeneity in multi-region non-small cell lung cancer patient-derived xenograft models. | Nat Commun | 2024 | https://conductscience.org/library/papers/38821942 | PubMed |
| 38641411 | Assessment of Patient-Derived Xenograft Growth and Antitumor Activity: The NCI PDXNet Consensus Recommendations. | Mol Cancer Ther | 2024 | https://conductscience.org/library/papers/38641411 | PubMed |
| 38289417 | Landscape of unconventional γδ T cell subsets in cancer. | Mol Biol Rep | 2024 | https://conductscience.org/library/papers/38289417 | PubMed |
| 38052483 | The Power and Promise of Patient-Derived Xenografts of Human Breast Cancer. | Cold Spring Harb Perspect Med | 2024 | https://conductscience.org/library/papers/38052483 | PubMed |
| 37296949 | Modeling the Tumor Microenvironment and Cancer Immunotherapy in Next-Generation Humanized Mice. | Cancers (Basel) | 2023 | https://conductscience.org/library/papers/37296949 | PubMed |
Genes17
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/36088362
GET https://conductscience.org/api/papers/v1/36088362/references?page=2